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Summary
The aim of this study was to investigate, by means of
transcranial Doppler ultrasound (TCD), cerebrovascu-
lar reactivity during the Valsalva maneuver (VM) during
the headache-free interval in patients with migraine (M),
migraine plus tension-type headache (M+TTH), and mi-
graine plus medication overuse headache (M+MOH). A
total of 114 patients (n=60 M, n=38 M+TTH, n=16
M+MOH) and n=60 controls were investigated; diag-
noses were made according to the International
Headache Society criteria. All subjects underwent TCD
monitoring and, simultaneously, non-invasive assess-
ment of arterial blood pressure and end-tidal CO2. Two
indices were determined: the cerebrovascular Valsalva
ratio (CVR) was calculated as the maximum end-dias-
tolic ﬂow velocity acceleration during the late straining
phase of the VM [cm/s2] and the centroperipheral Val-
salva ratio (CPVR) was deﬁned as the quotient of CVR
to the concomitant arterial blood pressure acceleration
[cm/mmHg x s]. 
The dynamic cerebrovascular autoregulatory response
to the VM, measured as CVR, was increased in patients
with M and M+TTH compared to age-matched healthy
subjects. By contrast, CPVR (i.e. the quotient of the
cerebrovascular to the peripheral autonomic re-
sponse), was increased in M patients compared to
healthy subjects and all other headache conditions
tested. 
Cerebrovascular autoregulatory response during the
VM was increased in M patients compared to age-
matched normal healthy subjects, indicating a dis-
turbed autonomic control of cerebral vasoreactivity.
The CPVR seems to be a sensitive parameter for distin-
guishing between M patients and M+TTH or M+MOH pa-
tients. 
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Introduction
Data on interictal cerebral vasoreactivity in migraine are
contradictory. Several complementary tests using trans-
cranial Doppler ultrasound (TCD) have been used to
evaluate the cerebrovascular autoregulatory response
in migraine during the headache-free interval, testing
cerebrovascular reactivity under rest conditions and us-
ing vasoconstrictor or vasodilator stimuli. The ﬁndings of
these TCD studies, which focused on recordings of
blood ﬂow velocity in basal cerebral arteries, were not
unequivocal. Some ﬁndings showed a moderate in-
crease in blood ﬂow (1-5) and others normal ﬂow veloc-
ity patterns (6-8). Studies analyzing cerebral vasoreac-
tivity have used different methods and stimuli, i.e. CO2,
hyperventilation, apnea, breath holding, cold pressure,
handgrip, head-up tilt, cognitive/motor tasks, and intra-
venous injection of acetazolamide. Most vasoconstrictor
stimuli studies demonstrated an increased response in
the headache-free interval in migraineurs (9-13). By
contrast, studies using vasodilator paradigms gave con-
tradictory results (14-16). Furthermore, a few studies
have investigated the cerebrovascular autoregulatory
(CA) response in other primary headaches, but none
has evaluated patients with migraine plus tension-type
headache (M+TTH) or migraine plus medication over-
use headache (M+MOH). 
There is evidence in the literature that migraine is a
chronic sympathetic nervous system disorder (17). Mi-
graine is characterized by an excessive response of in-
tracranial resistance vessels to metabolic stimulus.
However, analysis of dynamic CA response suggests
that there is a lack of autonomic control of cerebral
blood ﬂow (CBF) in migraine (18). Thus, it makes sense
to evaluate migraineurs using a paradigm known to
stimulate the sympathetically-mediated (CA) response. 
The Valsalva maneuver (VM), with its characteristic
rapid changes in arterial blood flow (or arterial blood
pressure, ABP), is an excellent paradigm for testing the
dynamic CA response. Liang et al. (19) using a compu-
tational model of the cardiovascular and autonomic
systems, observed that the VM-induced fall in cerebral
perfusion pressure during phase II of a VM leads to
compensatory vasodilatation of cerebral arterioles,
which might be mediated by sympathetic nerve func-
tion. 
The aim of the present study was to investigate, by
means of TCD, cerebrovascular and centroperipheral
autonomic response during the VM in migraine and in
migraine combined with other headaches (M+TTH and
M+MOH). 
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Materials and Methods
Population
A total of 114 patients [group A: 60 with M, mean age:
35+11 years (y); group B: 38 with M+TTH, mean age:
31+8 y; group C: 16 with M+MOH, mean age 47+10 y]
and a group of 60 healthy volunteers (group N, mean
age: 37+12 y) were studied after giving their informed
consent. Headache diagnoses were made using the cri-
teria set out in the International Headache Society’s In-
ternational Classiﬁcation of Headache Disorders, sec-
ond edition (20). Full general physical examination and
case history were performed by a senior neurologist. To
be included subjects had to be normotensive (ABP
<140/90 mmHg) and free from cardiovascular, metabol-
ic, pulmonary and psychiatric diseases. None had used
prophylactic medication during the previous three
months or any medication known to affect the autonom-
ic nervous system or cardiovascular system. The sub-
jects were asked to avoid alcohol-, nicotine-, or caffeine-
containing products for at least 12 hours prior to all ex-
aminations. All subjects underwent extracranial continu-
ous-wave Doppler ultrasound and a baseline TCD study
to rule out the presence of extra- or intracranial
stenoses. The local ethics committee approved the
study protocol. 
Methodology for measuring dynamic cerebral
autoregulation during the Valsalva maneuver
In all the subjects dynamic cerebral autoregulation dur-
ing the VM was measured using the TCD methodology.
During the examination, the subjects sat comfortably in
a quiet room. They performed a standardized VM as de-
scribed by Ewing (21): in short, they blew into a mouth-
piece connected to a modiﬁed sphygmomanometer and
maintained a pressure of 40 mmHg for a duration of 15
seconds. The TCD was performed as described by
Aaslid (22). Two commercially available dual TCD ultra-
sonographic devices were used, both speciﬁcally pre-
pared for dual-channel recordings (TC 2-64, EME, Über-
lingen, Germany). The middle cerebral artery (MCA)
was bilaterally insonated with ﬁxed 2 MHz pulsed
Doppler probes at a depth of 45-55 mm. Simultaneous-
ly, ABP was recorded continuously and noninvasively
using the Finapres system (Amsterdam, The Nether-
lands) (23). Additionally, end-tidal CO2 partial pressure(pCO2) was measured (Capnolog, Dräger, Lübeck, Ger-
many). All curves were monitored simultaneously using
an analog-digital transducer and data were stored using
a personal computer with specialized software (Daten-
logger, Rhothron, Homburg/Saar, Germany). For each
measurement, data were sent to an SPSS-readable ﬁle.
TCD examinations were performed during the
headache-free interval at least 24 hours after the last
migraine attack. The cerebrovascular Valsalva ratio
(CVR) was deﬁned as the maximum end diastolic ﬂow
velocity acceleration during the straining phase of the
VM (phase IIb) in cm/s2. It was calculated as follows:
CVR (cm/s2) = CBFVt2 (cm/s) – CBFVt1 (cm/s) / t2-t1 (s)
CVR=cerebrovascular Valsalva ratio; CBFV=cerebral blood ﬂow velocity;
t2-t1=time interval between measurements; s=second
The centroperipheral Valsalva ratio (CPVR) was instead
deﬁned as the quotient of CVR to the concomitant arte-
rial blood pressure acceleration in phase IIb (cm/mmHg
x s). It was calculated as follows: 
CPVR (cm/mmHg x s) =
CBFV t2 (cm/s) – CBFV t1 (cm/s) / t2-t1 (s)
ABP t2 (mmHg) – ABP t1 (mmHg) / t2-t1 (s)
CPVR=centroperipheral Valsalva ratio; CBFV=cerebral blood ﬂow veloci-
ty; ABP=arterial blood pressure; t2-t1=time interval between measure-
ments; s=second
Statistical analysis
Parameters were analyzed to identify signiﬁcant differ-
ences between groups (groups A-C) and controls. The
statistical evaluation was performed using Student’s t
test and Whitney-U test. For all tests, the level of signif-
icance was set at p<0.05.
Results
The clinical characteristics of the patients are given in
Table 1. There were no signiﬁcant differences in age be-
tween the groups (A/N, p=0.717, n.s.; B/A, p=0.358,
n.s.; C/A, p=0.230, n.s.). The results of the patients in
group A (M) differed signiﬁcantly from those recorded in
the age-matched healthy subjects (CVR r/l =
0.001/0.001 and CPVR r/l = 0.001/0.001) and in the
group B (M+TTH) patients (CVR r/l = 0.011/0.009 and
T.-M. Wallasch et al.
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Table 1 - Demographics and clinical characteristics of patients
M M+TTH M+MOH
(Group A) (Group B) (Group C)
Age (years ± SD) 34 ± 11 31 ± 8 47 ± 10 
Gender  female (%) 83.3 84.2 87.5
male (%) 16.7 15.8 12.5 
BMI (kg/m2) 22.2 22.6 23.5
Family history of headache (%) 73.3 60.5 87.5
Migraine attacks / month ± SD 3.0 ± 2.1 2.2 ± 1.3 4.6 ± 2.8
Intake of analgesics / month ± SD 3.0 ± 3.9 8.7 ± 9.8 49.0 ± 41.0
Intake of triptans / month ± SD 2.2 ± 4.9 1.3 ± 2.9 6.4 ± 8.5
Abbreviations: M=migraine; M+TTH=migraine and tension-type headache; M+MOH=migraine and medication overuse headache. 
CPVR r/l = 0.001/0.001). The results of group A (M)
compared to those of group C (M+MOH) showed no sig-
niﬁcant difference in CVR, but signiﬁcant differences in
CPVR (r/l = 0.001/0.001) (Table 2). No correlations
emerged between changes in end-tidal pCO2 and meas-
urements of CBFV and ABP.
Discussion
Testing cerebral vasomotor reactivity using TCD and
continuous ABP recordings during the VM, which is
characterized by rapid and distinct changes in ABP,
seems to be an adequate method of provoking and as-
sessing the CA response, which might be based on
compensatory sympathetically-mediated vasodilatation
of the small cerebral vessels (19,24-27). Additionally,
vasoreactivity during the VM is not affected by end-tidal
pCO2 changes (28). 
Altered cerebral vasoreactivity has been implicated in
migraine. In the present study, vasomotor reactivity in
patients with M was found to show characteristic ﬂow
velocity abnormalities. Therefore, we determined two in-
dices to quantify cerebrovascular (CVR) and centrope-
ripheral (CPVR) dynamic CA responses. CVR reﬂects
the vasomotor reactivity of the MCA vascular territories
during the late straining phase of the VM (phase IIb),
while CPVR represents the quotient of the central to the
peripheral autoregulatory response concomitant to the
dynamic vascular changes occurring during phase IIb.
Both CVR and CPVR were found to be increased in M
in comparison with age-matched healthy controls.
These results are in accordance with most TCD studies,
which showed exaggerated interictal cerebrovascular
reactivity in M (1-3,10,14,28). Our observation supports
the hypothesis that M is associated with an abnormality
in the mechanism of the CA response (17). Support for
our theory of sympathetically-mediated hyper-respon-
siveness in M is provided by the observations of Micieli
et al. (12), who recorded different functional noradrener-
gic reactivity in M compared with healthy controls using
cold pressure testing. Additionally, Müller and Marziniak
(18) found impaired cerebrovascular autoregulation in M
using frequency analysis of the dynamic CA response.
To the best of our knowledge, this is the ﬁrst study to use
TCD ultrasound to investigate the dynamic CA response
not only in M alone, but also in M plus other headaches.
Patients suffering from M+TTH showed increased CVR
and CPVR indices, although the values were signiﬁcant-
ly lower than those recorded in M. These ﬁndings sug-
gest that patients with M+TTH might show a lack of au-
tonomic control of CBF, as has already been suggested
in patients with M (18). However, the combination of the
two headache disorders might have reduced the sympa-
thetic hyper-responsiveness. In other TCD studies,
there was no evidence of altered CA response in TTH
(29,30). 
We failed to detect signiﬁcant differences in CVR (i.e.
CA response) between M and combined M+MOH. Con-
versely, there did emerge a signiﬁcant difference in
CPVR between these groups, which seems to indicate
that the quotient of cerebrovascular to peripheral au-
toregulatory response during phase IIb of the VM is the
more sensitive parameter of autonomic dysregulation.
The M+MOH group patients had a higher mean age
than the other study subgroups, and this difference, in
particular, might explain our ﬁndings. Patients with MOH
regularly present a long disease duration and it is possi-
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Table 2 - Cerebrovascular Valsalva ratio (cm/s2) and centroperipheral Valsalva ratio (cm/mmHg x s) for right(r)and left(l) side
MCA measurements 
GROUP A (M) GROUP B (M+TTH) GROUP C (M+MOH) N (controls)
n=60 n=38 n=16 n=60
CVR (r) (l) (r) (l) (r) (l) (r) (l)
8.08 (3.22) 8.03 (3.31) 6.64 (2.78) 6.47 (2.68) 4.78 (2.80) 4.55 (2.58) 4.74 (1.64) 4.66 (1.70) right: A vs N: p < .001
A vs B: p < .01
A vs C: p > .01
left: A vs N: p < .001
A vs B: p > .05
A vs C: p > .05
CPVR (r) (l) (r) (l) (r) (l) (r) (l)
1.60 (0.60) 1.53 (0.46) 1.19 (0.45) 1.15 (0.83) 0.89 (0.39) 0.82 (0.30) 0.97 (0.21) 0.95 (0.22) right: A vs N: p < .001
A vs B: p < .001
A vs C: p < .001
left: A vs N: p < .001
A vs B: p < .001
A vs C: p < .001
Abbreviations: CVR=cerebrovascular Valsalva ratio; CPVR=centroperipheral Valsalva ratio; M=patients with migraine only;
M+TTH=patients with migraine + tension-type headache; M+MOH=patients with migraine + medication overuse headache; N=age-
matched group of normal healthy controls. Statistical tests refer to comparisons between headache groups (Student´s t-test).
ble that chronic sympathetic hyper-responsiveness
might decrease over time. There are sparse data on
CBFV and none on cerebrovascular reactivity evaluated
with TCD in MOH patients. Savrun et al. (31) reported
elevated CBFVs in the middle cerebral and basilar arter-
ies in MOH induced by ergotamine abuse, but not in
MOH caused by analgesic overuse. By contrast, Diener
et al. (32) did not observe CBFV changes induced by er-
gotamine or sumatriptan treatment. Atasoy et al. (33) re-
ported changes in sympathetic skin response latencies
in migraine and MOH patients, which were signiﬁcantly
longer than those recorded in controls, but also mainly
affected by comorbid psychiatric diseases, which often
occur in MOH. Further studies should pay particular at-
tention to these problematic points.
Our study has some limitations. In particular, the time
from the last attack, or to the next one, might be cru-
cial, as shown in other studies concerning headache
disorders (34). In our study, recordings were made in
the headache-free interval and a minimum of 24 hours
had to have elapsed since the last migraine attack.
Therefore we can confirm that the interval since the
last attack was always more than one day. However,
there was no standardization of timing of measure-
ments during the interictal period and this circum-
stance might have influenced our results. In accor-
dance with the study protocol TCD recordings during a
migraine attack were excluded, as was any intake of
medication. 
In conclusion, the results of our study support the hy-
pothesis of a sympathetically-mediated hyper-respon-
siveness in M during the headache-free interval. Sever-
al investigators using different stimuli have demonstrat-
ed, through TCD ultrasound, an elevated interictal CA
response in M. Our ﬁndings are in accordance with
these observations. The CPVR seems to be a suitable
index for testing dynamic autoregulatory response in mi-
grainous headaches and for distinguishing between mi-
graineurs with and without additional headaches such
as TTH and MOH. Further work is needed to clarify the
autonomic and hemodynamic alterations in MOH and
other headaches.
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